The Resilience of Early-stage European Healthtech
Total funding for Pre-seed to Series B European healthtech companies grew 49% YoY from 2020 to 2021 and remained resilient in 2022 with an 8% YoY growth, reaching $4.4 billion.
Octopus Ventures
Venture capital · GB · 2 documents · Website
Entrepreneurial Impact Ranking 2020
The 2018/2019 academic year was a record year for spinout exits from UK universities, with sales of spinout company shares totalling more than £61 million, an increase of 37% from 2017/2018.